m⁶A-Mediated Upregulation of lncRNA RMRP Boosts the Progression of Bladder Cancer Via Epigenetically Suppressing SCARA5

References

• Lenis AT , LecPM, ChamieK, MshsM. Bladder cancer: a review. JAMA324(19), 1980–1991 (2020).
   PubMed Web of Science ®Google Scholar
• Kamat AM , HahnNM, EfstathiouJAet al. Bladder cancer. Lancet388(10061), 2796–2810 (2016).
   PubMed Web of Science ®Google Scholar
• Aldousari S , KassoufW. Update on the management of non-muscle invasive bladder cancer. Can. Urol. Assoc. J.4(1), 56–64 (2010).
   PubMed Web of Science ®Google Scholar
• Statello L , GuoC-J, ChenL-L, HuarteM. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol.22(2), 96–118 (2021).
   PubMed Web of Science ®Google Scholar
• Liu SJ , DangHX, LimDA, FengFY, MaherCA. Long noncoding RNAs in cancer metastasis. Nat. Rev. Cancer21(7), 446–460 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ChenX, LinJ, JinX. Biological functions and clinical significance of long noncoding RNAs in bladder cancer. Cell Death Discov.7(1), 278 (2021).
   PubMed Web of Science ®Google Scholar
• Taheri M , OmraniMD, Ghafouri-FardS. Long non-coding RNA expression in bladder cancer. Biophys. Rev.10(4), 1205–1213 (2018).
   PubMedGoogle Scholar
• Cao Q , WangN, QiJ, GuZ, ShenH. Long non-coding RNA- GAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (C-C motif) ligand 1 expression. Mol. Med. Rep.13(1), 27–34 (2016).
   PubMed Web of Science ®Google Scholar
• Wang YY , WuZY, WangGCet al. LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p. Tumour Biol.37(11), 14553–14563 (2016).
   PubMedGoogle Scholar
• Mirzaei S , PaskehMDA, HashemiFet al. Long non-coding RNAs as new players in bladder cancer: lessons from pre-clinical and clinical studies. Life Sci.288, 119948 (2022).
   PubMed Web of Science ®Google Scholar
• Cao HL , LiuZJ, HuangPL, YueYL, XiJN. lncRNA- RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. Eur. Rev. Med. Pharmacol. Sci.23(3), 1012–1021 (2019).
   PubMed Web of Science ®Google Scholar
• Peng Q , LiuY, KongXet al. The novel methylation biomarker SCARA5 sensitizes cancer cells to DNA damage chemotherapy drugs in NSCLC. Front. Oncol.11, 666589 (2021).
   PubMed Web of Science ®Google Scholar
• Yan N , ZhangS, YangYet al. Therapeutic upregulation of class A scavenger receptor member 5 inhibits tumor growth and metastasis. Cancer Sci.103(9), 1631–1639 (2012).
   PubMed Web of Science ®Google Scholar
• You K , SuF, LiuLet al. SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways. Mol. Cell. Biochem.435(1), 47–58 (2017).
   PubMed Web of Science ®Google Scholar
• Liu SC , CaoYH, ChenLB, KangR, HuangZX, LuXS. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression. Cancer Biol. Ther.23(1), 1–13 (2022).
   PubMed Web of Science ®Google Scholar
• Yin H , ChenL, PiaoSet al. M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway. Cell Death Differ.30(3), 605–617 (2021).
   PubMed Web of Science ®Google Scholar
• Pagliaro LC , SharmaP. Review of metastatic bladder cancer. Minerva Urol. Nefrol.58(1), 53–71 (2006).
   PubMedGoogle Scholar
• Huarte M . The emerging role of lncRNAs in cancer. Nat. Med.21(11), 1253–1261 (2015).
   PubMed Web of Science ®Google Scholar
• Gao N , LiY, LiJet al. Long non-coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers. Front. Oncol.10, 598817 (2020).
   PubMed Web of Science ®Google Scholar
• Li HJ , GongX, LiZKet al. Role of long non-coding RNAs on bladder cancer. Front. Cell Dev. Biol.9, 672679 (2021).
   PubMedGoogle Scholar
• Hussen BM , AzimiT, HidayatHJ, TaheriM, Ghafouri-FardS. Long non-coding RNA RMRP in the pathogenesis of human disorders. Front. Cell Dev. Biol.9, 676588–676588 (2021).
   PubMed Web of Science ®Google Scholar
• Hao Q , LuH, ZhouX. A potential synthetic lethal strategy with PARP inhibitors: perspective on ‘Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP’. J. Mol. Cell Biol.13(9), 690–692 (2021).
   PubMed Web of Science ®Google Scholar
• Wang J , WangS, ChenL, TanJ. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway. Mol. Med. Rep.23(3), 202 (2021).
   PubMed Web of Science ®Google Scholar
• Ulker D , ErsoyYE, GucinZ, MuslumanogluM, BuyruN. Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation. Gene673, 102–106 (2018).
   PubMed Web of Science ®Google Scholar
• Liu H , HuJ, WeiRet al. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation. J. Exp. Clin. Cancer Res.37(1), 229 (2018).
   PubMedGoogle Scholar
• Georgopoulos P , PapaioannouM, MarkopoulouS, FragouA, KouvatseasG, ApostolidisA. DNA hypermethylation af a panel of genes as an urinary biomarker for bladder cancer diagnosis. Urol. J.19(3), 214–220 (2021).
   PubMed Web of Science ®Google Scholar
• Koudonas A , PapaioannouM, KampantaisS, AnastasiadisA, HatzimouratidisK, DimitriadisG. Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: a cohort study. Medicine (Baltimore)101(28), e29599 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang H , LiuC, WangX, WangY, ZhengJ. SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression. J. Cancer12(8), 2412–2421 (2021).
   PubMed Web of Science ®Google Scholar
• Zhao Y , SunH, WangH. Long noncoding RNAs in DNA methylation: new players stepping into the old game. Cell Biosci.6(1), 45 (2016).
   PubMedGoogle Scholar
• Xu SF , ZhengY, ZhangLet al. Long non-coding RNA LINC00628 interacts epigenetically with the LAMA3 promoter and contributes to lung adenocarcinoma. Mol. Ther. Nucleic Acids18, 166–182 (2019).
   PubMedGoogle Scholar
• Drak Alsibai K , VacherS, MeseureDet al. High positive correlations between ANRIL and p16- CDKN2A/ p15- CDKN2B/ p14- ARF gene cluster overexpression in multi-tumor types suggest deregulated activation of an ANRIL– ARF bidirectional promoter. Noncoding RNA5(3), 44 (2019).
   PubMed Web of Science ®Google Scholar
• Liu Q . Current advances in N6-methyladenosine methylation modification during bladder cancer. Front. Genet.12, 825109 (2021).
   PubMed Web of Science ®Google Scholar
• Wu Y , YangX, ChenZet al. m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1. Mol. Cancer18(1), 87 (2019).
   PubMedGoogle Scholar
• Zheng ZQ , LiZX, ZhouGQet al. Long noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3. Cancer Res.79(18), 4612–4626 (2019).
   PubMed Web of Science ®Google Scholar